Acyloxyacyl hydrolase modulates depressive-like behaviors through aryl hydrocarbon receptor

MAPP Research Network Study Group

Research output: Contribution to journalArticle

Abstract

Corticotropin-releasing factor (CRF) regulates stress responses, and aberrant CRF signals are associated with depressive disorders. Crf expression is responsive to arachidonic acid (AA), where CRF is released from the hypothalamic paraventricular nucleus (PVN) to initiate the hypothalamic-pituitary-adrenal axis, culminating in glucocorticoid stress hormone release. Despite this biological and clinical significance, Crf regulation is unclear. Here, we report that acyloxyacyl hydrolase, encoded by Aoah, is expressed in the PVN, and Aoah regulates Crf through the aryl hydrocarbon receptor (AhR). We previously showed that AOAH-deficient mice mimicked interstitial cystitis/bladder pain syndrome, a condition frequently associated with comorbid anxiety and depression. With the use of novelty-suppressed feeding and sucrose preference assays to quantify rodent correlates of anxiety/depression, AOAH-deficient mice exhibited depressive behaviors. AOAH-deficient mice also had increased CNS AA, increased Crf expression in the PVN, and elevated serum corticosterone, consistent with dysfunction of the hypothalamic-pituitary-adrenal axis. The human Crf promoter has putative binding sites for AhR and peroxisome proliferator-activated receptor (PPARγ). PPARγ did not affect AA-dependent Crf expression in vitro, and conditional Pparγ knockout did not alter the AOAH-deficient depressive phenotype, despite previous studies implicating PPARγ as a therapeutic target for depression. In contrast, Crf induction was mediated by AhR binding sites in vitro and increased by AhR overexpression. Furthermore, conditional Ahr knockout rescued the depressive phenotype of AOAH-deficient mice. Finally, an AhR antagonist rescued the AOAH-deficient depressive phenotype. Together, our results demonstrate that Aoah is a novel genetic regulator of Crf mediated through AhR, and AhR is a therapeutic target for depression.

Original languageEnglish (US)
Pages (from-to)R289-R300
JournalAmerican journal of physiology. Regulatory, integrative and comparative physiology
Volume317
Issue number2
DOIs
StatePublished - Aug 1 2019

Fingerprint

Aryl Hydrocarbon Receptors
Peroxisome Proliferator-Activated Receptors
Paraventricular Hypothalamic Nucleus
Corticotropin-Releasing Hormone
Arachidonic Acid
Depression
Phenotype
Anxiety
Binding Sites
Interstitial Cystitis
Depressive Disorder
Corticosterone
acyloxyacyl hydrolase
Glucocorticoids
Sucrose
Rodentia
Urinary Bladder
Hormones
Pain
Therapeutics

Keywords

  • AhR
  • AOAH
  • arachidonic acid
  • CRF
  • interstitial cystitis
  • stress

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

@article{856b4d37293c43a5999510d78303ebd0,
title = "Acyloxyacyl hydrolase modulates depressive-like behaviors through aryl hydrocarbon receptor",
abstract = "Corticotropin-releasing factor (CRF) regulates stress responses, and aberrant CRF signals are associated with depressive disorders. Crf expression is responsive to arachidonic acid (AA), where CRF is released from the hypothalamic paraventricular nucleus (PVN) to initiate the hypothalamic-pituitary-adrenal axis, culminating in glucocorticoid stress hormone release. Despite this biological and clinical significance, Crf regulation is unclear. Here, we report that acyloxyacyl hydrolase, encoded by Aoah, is expressed in the PVN, and Aoah regulates Crf through the aryl hydrocarbon receptor (AhR). We previously showed that AOAH-deficient mice mimicked interstitial cystitis/bladder pain syndrome, a condition frequently associated with comorbid anxiety and depression. With the use of novelty-suppressed feeding and sucrose preference assays to quantify rodent correlates of anxiety/depression, AOAH-deficient mice exhibited depressive behaviors. AOAH-deficient mice also had increased CNS AA, increased Crf expression in the PVN, and elevated serum corticosterone, consistent with dysfunction of the hypothalamic-pituitary-adrenal axis. The human Crf promoter has putative binding sites for AhR and peroxisome proliferator-activated receptor (PPARγ). PPARγ did not affect AA-dependent Crf expression in vitro, and conditional Pparγ knockout did not alter the AOAH-deficient depressive phenotype, despite previous studies implicating PPARγ as a therapeutic target for depression. In contrast, Crf induction was mediated by AhR binding sites in vitro and increased by AhR overexpression. Furthermore, conditional Ahr knockout rescued the depressive phenotype of AOAH-deficient mice. Finally, an AhR antagonist rescued the AOAH-deficient depressive phenotype. Together, our results demonstrate that Aoah is a novel genetic regulator of Crf mediated through AhR, and AhR is a therapeutic target for depression.",
keywords = "AhR, AOAH, arachidonic acid, CRF, interstitial cystitis, stress",
author = "{MAPP Research Network Study Group} and Aguiniga, {Lizath M.} and Wenbin Yang and Yaggie, {Ryan E.} and Schaeffer, {Anthony J} and David Klumpp",
year = "2019",
month = "8",
day = "1",
doi = "10.1152/ajpregu.00029.2019",
language = "English (US)",
volume = "317",
pages = "R289--R300",
journal = "American Journal of Physiology",
issn = "0363-6119",
publisher = "American Physiological Society",
number = "2",

}

Acyloxyacyl hydrolase modulates depressive-like behaviors through aryl hydrocarbon receptor. / MAPP Research Network Study Group.

In: American journal of physiology. Regulatory, integrative and comparative physiology, Vol. 317, No. 2, 01.08.2019, p. R289-R300.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Acyloxyacyl hydrolase modulates depressive-like behaviors through aryl hydrocarbon receptor

AU - MAPP Research Network Study Group

AU - Aguiniga, Lizath M.

AU - Yang, Wenbin

AU - Yaggie, Ryan E.

AU - Schaeffer, Anthony J

AU - Klumpp, David

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Corticotropin-releasing factor (CRF) regulates stress responses, and aberrant CRF signals are associated with depressive disorders. Crf expression is responsive to arachidonic acid (AA), where CRF is released from the hypothalamic paraventricular nucleus (PVN) to initiate the hypothalamic-pituitary-adrenal axis, culminating in glucocorticoid stress hormone release. Despite this biological and clinical significance, Crf regulation is unclear. Here, we report that acyloxyacyl hydrolase, encoded by Aoah, is expressed in the PVN, and Aoah regulates Crf through the aryl hydrocarbon receptor (AhR). We previously showed that AOAH-deficient mice mimicked interstitial cystitis/bladder pain syndrome, a condition frequently associated with comorbid anxiety and depression. With the use of novelty-suppressed feeding and sucrose preference assays to quantify rodent correlates of anxiety/depression, AOAH-deficient mice exhibited depressive behaviors. AOAH-deficient mice also had increased CNS AA, increased Crf expression in the PVN, and elevated serum corticosterone, consistent with dysfunction of the hypothalamic-pituitary-adrenal axis. The human Crf promoter has putative binding sites for AhR and peroxisome proliferator-activated receptor (PPARγ). PPARγ did not affect AA-dependent Crf expression in vitro, and conditional Pparγ knockout did not alter the AOAH-deficient depressive phenotype, despite previous studies implicating PPARγ as a therapeutic target for depression. In contrast, Crf induction was mediated by AhR binding sites in vitro and increased by AhR overexpression. Furthermore, conditional Ahr knockout rescued the depressive phenotype of AOAH-deficient mice. Finally, an AhR antagonist rescued the AOAH-deficient depressive phenotype. Together, our results demonstrate that Aoah is a novel genetic regulator of Crf mediated through AhR, and AhR is a therapeutic target for depression.

AB - Corticotropin-releasing factor (CRF) regulates stress responses, and aberrant CRF signals are associated with depressive disorders. Crf expression is responsive to arachidonic acid (AA), where CRF is released from the hypothalamic paraventricular nucleus (PVN) to initiate the hypothalamic-pituitary-adrenal axis, culminating in glucocorticoid stress hormone release. Despite this biological and clinical significance, Crf regulation is unclear. Here, we report that acyloxyacyl hydrolase, encoded by Aoah, is expressed in the PVN, and Aoah regulates Crf through the aryl hydrocarbon receptor (AhR). We previously showed that AOAH-deficient mice mimicked interstitial cystitis/bladder pain syndrome, a condition frequently associated with comorbid anxiety and depression. With the use of novelty-suppressed feeding and sucrose preference assays to quantify rodent correlates of anxiety/depression, AOAH-deficient mice exhibited depressive behaviors. AOAH-deficient mice also had increased CNS AA, increased Crf expression in the PVN, and elevated serum corticosterone, consistent with dysfunction of the hypothalamic-pituitary-adrenal axis. The human Crf promoter has putative binding sites for AhR and peroxisome proliferator-activated receptor (PPARγ). PPARγ did not affect AA-dependent Crf expression in vitro, and conditional Pparγ knockout did not alter the AOAH-deficient depressive phenotype, despite previous studies implicating PPARγ as a therapeutic target for depression. In contrast, Crf induction was mediated by AhR binding sites in vitro and increased by AhR overexpression. Furthermore, conditional Ahr knockout rescued the depressive phenotype of AOAH-deficient mice. Finally, an AhR antagonist rescued the AOAH-deficient depressive phenotype. Together, our results demonstrate that Aoah is a novel genetic regulator of Crf mediated through AhR, and AhR is a therapeutic target for depression.

KW - AhR

KW - AOAH

KW - arachidonic acid

KW - CRF

KW - interstitial cystitis

KW - stress

UR - http://www.scopus.com/inward/record.url?scp=85070421377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070421377&partnerID=8YFLogxK

U2 - 10.1152/ajpregu.00029.2019

DO - 10.1152/ajpregu.00029.2019

M3 - Article

C2 - 31017816

AN - SCOPUS:85070421377

VL - 317

SP - R289-R300

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6119

IS - 2

ER -